Association between Company’s Medical Artificial Intelligence and Growth Opportunities
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The technological and industrial advancements in the field of medical artificial intelligence (AI) may be associated with the rapid growth of companies in this sector. The purpose of this study was to examine the relationship between the growth opportunities in the medical AI industry and companies engaged in one or more AI-related businesses. Secondary data analysis was performed using the 2021 artificial intelligence industry survey data collected from September 2021 to November 2021. In order to observe the relationship between the medical artificial intelligence industry and company growth opportunities, the medical artificial intelligence industry, company growth opportunities, difficulties, Artificial intelligence start year, Main business field, sales volume, listing status, corporate affiliated research institute, AI main business, Percentage of Data Utilization variables, Rao-Scott cross-test, and logistic regression analysis including covariates were performed. Among all companies, when the AI application industry included medical AI, the OR for the company growth opportunities was 1.80 (P-value 0.031, 95% CI 1.06-3.06). For the medical artificial intelligence industry, the OR was 2.28 (P-value 0.016, 95% CI 1.17-4.46). In artificial intelligence companies, medical artificial intelligence-related industries can play a role in enhancing the growth potential of companies. In order to improve the growth potential of artificial intelligence companies, there is a need to consider the implementation of medical artificial intelligence-related industries and implement support policies that consider the timing of the company’s entry into the artificial intelligence industry. Therefore, the government needs to revise industry policies to actively establish laws, regulations, and policies, and further enable medical AI to perform a smooth role as a new growth engine.
Abstract
The technological and industrial advancements in the field of medical artificial intelligence (AI) may be associated with the rapid growth of companies in this sector. The purpose of this study was to examine the relationship between the growth opportunities in the medical AI industry and companies engaged in one or more AI-related businesses. Secondary data analysis was performed using the 2021 artificial intelligence industry survey data collected from September 2021 to November 2021. In order to observe the relationship between the medical artificial intelligence industry and company growth opportunities, the medical artificial intelligence industry, company growth opportunities, difficulties, Artificial intelligence start year, Main business field, sales volume, listing status, corporate affiliated research institute, AI main business, Percentage of Data Utilization variables, Rao-Scott cross-test, and logistic regression analysis including covariates were performed. Among all companies, when the AI application industry included medical AI, the OR for the company growth opportunities was 1.80 (P-value 0.031, 95% CI 1.06-3.06). For the medical artificial intelligence industry, the OR was 2.28 (P-value 0.016, 95% CI 1.17-4.46). In artificial intelligence companies, medical artificial intelligence-related industries can play a role in enhancing the growth potential of companies. In order to improve the growth potential of artificial intelligence companies, there is a need to consider the implementation of medical artificial intelligence-related industries and implement support policies that consider the timing of the company’s entry into the artificial intelligence industry. Therefore, the government needs to revise industry policies to actively establish laws, regulations, and policies, and further enable medical AI to perform a smooth role as a new growth engine.
참고문헌 (35)
- Ahn, J. M., "Comparative analysis of the economic ripple effect of the digital healthcare industry and the telemedicine industry", The e-Business Studies, 22(5), pp.15~25 (2021)
- Trends in the global healthcare service market and major key technology, "institutional issues", Ahn, S. H., 2022, pp.140~
- Apell, P., "Artificial intelligence (AI) healthcare technology innovations:the current state and challenges from a life science industry perspective", Technology Analysis & Strategic Management, pp.1~15 (2021)
- Atuahene-Gima, K., "An empirical investigation of the effect of market orientation and entrepreneurship orientation alignment on product innovation", Organization Science, 12(1), pp.54~74 (2001)
- Cha, Y. R., "Artificial intelligence strategy for advertising and media industries : focused on in-depth interviews", The Journal of the Korea Contents Association, 18(9), pp.102~115 (2018)
- David, P. A., "Is public R&D a complement or substitute for private R&D? A review of the econometric evidence", Research Policy, 29(4-5), pp.497~529 (2000)
- Artificial intelligence (AI) market in healthcare sector, "Foundation, K. I.", ~ (2021)
- Gerber, A., "Enterprise architecture as explanatory information systems theory for understanding small-and medium-sized enterprise growth", Sustainability, 12(20), pp.8517~ (2020)
- González, X., "Do public subsidies stimulate private R&D spending", Research Policy, 37(3), pp.371~389 (2008)
- Group, B. C., "Perspectives on experience" (1968)
- Heo, Y. S., "AI Medical and Healthcare", ASTI MARKET INSIGHT (2022)
- Hillman, A. J., "Corporate political strategy formulation : a model of approach, participation, and strategy decisions", Academy of Management Review, 24(4), pp.825~842 (1999)
- Hong, J. P., "An analysis of determinants for artificial intelligence industry competitiveness", Journal of the Korea Institute of Information and Communication Engineering, 21(4), pp.663~671 (2017)
- ICT, M. o. S. a, "High-speed drug development platform using artificial intelligence (AI) + big data, to be released in 2019 - Significantly shortening the development period of new drug candidates from 5 years to 1 year-", ~ (2019)
- ICT, M. o. S. a., "Artificial intelligence (AI) R&D strategy for the realization of I-Korea 4.0", ~ (2018)
- ICT, M. o. S. a., "2021 Artificial Intelligence Industry Survey", ~ (2022)
- Jacobs, D., "Enterprise architecture for small and medium enterprise growth", Advances in Enterprise Engineering V: First Enterprise Engineering Working Conference, EEWC 2011, 1, pp.61~75 (2011), Springer Berlin Heidelberg
- Kim, H. C., "Industrial digital transformation, geopolitics and new trade agenda", International Trade Law, 158, pp.3~57 (2023)
- Kim, J. S., "Metaverse utilization and legal issues in healthcare", The Justice, 194(3), pp.233~263 (2023)
- Kim, K. B., "A study of the digital healthcare industry in the fourth industrial revolution", Journal of Convergence for Information Technology, 10(3), pp.7~15 (2020)
- Kim, Y. J., "Understanding and application of multi-task learning in medical artificial intelligence", Journal of the Korean Society of Radiology, 83(6), pp.1208~1218 (2022)
- Kim, Y. K., "A technology-based IPO in Korea’s AI medical business - Vuno Case -", The Korea Enterpreneurship Society, 17(3), pp.27~52 (2022)
- Lach, S., "Do R&D subsidies stimulate or displace private R&D? Evidence from Israel", The Journal of Industrial Economics, 50(4), pp.369~390 (2002)
- Lambe, C. J., "Alliances, external technology acquisition, and discontinuous technological change", Journal of Product Innovation Management : An International Publication of the Product Development & Management Association, 14(2), pp.102~116 (1997)
- Lee, H. B., "Exploring the applicability of artificial intelligence for the improvement of nursing practice in Korea", Journal of Korean Academy of Nursing Administration, 29(5), pp.564~576 (2023)
- Current status and challenges of medical artificial intelligence, "Lee, K. Y.", ~, pp.Health Industry Brief, 219 (2016)
- Lee, S. H., "Artificial intelligence technology trend based on medical big data", The Korean Institute of Commucations and Information Sciences (Information and Communications Magazine), 37(9), pp.85~91 (2020)
- Meyer, M. H., "Innovation and enterprise growth", Research-Technology Management, 48(4), pp.34~44 (2005)
- Ministries, J., "National strategy for artificial intelligence", ~ (2019)
- Ministries, J., "Strategies for fostering the digital healthcare service industry", ~ (2022)
- Shin, S. Y., "Current status and future direction of digital health in Korea", The Korean Journal of Physiology & Pharmacology, 23(5), pp.311~315 (2019)
- Welfare, M. o. H. a., "Health care data AI innovation strategy “Going to a healthy future” - Health Data F.L.O.W. 2025 -", ~ (2021)
- Yoon, Y. G., "Effects of R&D activities and support policies on corporate employment and management performance", Labor Review, pp.23~42 (2020)
- Yu, S. J., "The 4th industrial revolution and artificial intelligence", Korea Multimedia Society, 21(4), pp.1~8 (2017)
- Zúñiga-Vicente, J. Á., "Assessing the effect of public subsidies on firm R&D investment : a survey", Journal of Economic Surveys, 28(1), pp.36~67 (2014)